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IFN-  in the late phase. The NPT was continuously dominat-
ed by IFN-  . Dendritic cell subpopulations imitated the ear-
lier kinetics of the mononuclear infiltrate.  Discussion: Thus, 
pollen grains induce eczematous reactions in susceptible in-
dividuals. This reaction appears clinically and immunohisto-
chemically similar to the contact hypersensitivity reaction to 
nickel but follows a faster kinetic and a biphasic course: Th2 
and IgE in the early (24 h) and Th1 predominance in the late 
(96 h) phase.  Copyright © 2007 S. Karger AG, Basel
 Introduction
 Atopic eczema (AE)  [1] is a chronic relapsing inflam-
matory skin disease which is often associated with asth-
ma and/or hay fever and a positive family history of atopy. 
Its main features are eczematous skin lesions with a typ-
ical, age-related distribution and severe pruritus  [2, 3] . It 
is a disease caused by combined influences of genetic and 
environmental factors  [4] leading to a Th2-dominated 
immune response against various allergens  [5] . Skin ir-
ritants, systemic or local infections, environmental pol-
lutants, stress and hormonal changes may play an aggra-
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 Abstract
 Introduction: Eczematous reactions to type I allergy-induc-
ing antigens are documented in a subgroup of patients with 
atopic eczema. Yet, the underlying immunological mecha-
nisms are not well understood.  Material and Methods: To 
delineate the effect of native pollen grains on human skin of 
healthy and atopic individuals we performed patch tests (at-
opy patch test with native pollen grains, PPT). Nickel patch 
tests (NPT) served as an established model of contact der-
matitis. Skin site biopsies were taken 6–96 h after allergen 
application and investigated immunohistochemically.  Re-
sults: Histology of positive patch tests showed an influx of 
mononuclear cells (predominantly CD4+, CD25+, CD45RO+). 
This influx was detected earlier in the PPT reaction than in 
the immune response to nickel. A biphasic cytokine response 
could be detected in the PPT: IL-5 dominated in the early, 
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vating role in the pathophysiology of AE  [6, 7] . Especial-
ly aeroallergens may induce eczema flares  [8, 9] .
 Current concepts follow the idea that allergens are able 
to penetrate the barrier-disturbed epidermis  [10] where 
they are taken up by Langerhans cells which migrate to 
the regional lymph nodes and present the novel antigen 
to naïve T cells  [11] . The relationship between antigen ex-
posure via pollen grains and disease activity was already 
demonstrated as early as 1949  [12] . Notably, most recent-
ly a population-based panel study demonstrated that out-
door grass pollen exposure significantly exacerbated 
symptoms in children with eczema, especially in those 
sensitized against grass pollen  [13] . These studies suggest 
that allergens which are known to induce type I allergy 
with the typical Th2-dominated immune response and 
production of specific IgE antibodies are also involved in 
the elicitation of eczematous reactions. The atopy patch 
test (APT) has been used as a model for early AE lesions 
 [14, 15] and is performed with protein extracts of the re-
spective allergen carrier, e.g. house dust mite or pollen 
 [16, 17] . The standardized APT technique has been devel-
oped in a series of multicentre trials and is regarded to be 
a suitable and reproducible procedure for evaluating the 
clinical relevance of IgE sensitization for eczematous skin 
lesions  [18–20] . Since pollen themselves release not only 
allergens, but are rather a package of myriads of sub-
stances including the recently described proinflamma-
tory and immunomodulatory lipid mediators ( pollen-as-
sociated lipid mediators – PALMs)  [21–24] , we exposed 
our patients and controls to native pollen grains. 
 The present study aims at analyzing an eczematous 
reaction to classically type I, IgE-mediated allergy-induc-
ing agents. Since an eczematous reaction is traditionally 
contributed to type IV hypersensitivity-inducing agents 
we took the nickel patch tests (NPT) as reference inflam-
matory skin reaction in order to classify pollen eczema-
tous reaction in the traditional model of types of hyper-
sensitivity reactions to environmental substances.
 Materials and Methods
 Patients and Subjects
 For the analysis of the time course of an acute eczematous re-
action two different main groups were enrolled into the study fol-
lowing the declaration of Helsinki protocols after written in-
formed consent had been given. (1) Patients with AE (n = 6) diag-
nosed according to the criteria of Hanifin and Rajka  [25] sensitized 
against grass and/or birch pollen (specific IgE class 3 or higher) 
and with a positive APT. Allergen-specific and total IgE levels in 
serum were determined by CAP-FEIA (Pharmacia, Uppsala, Swe-
den). (2) Patients with positive NPT (n = 5) but negative personal 
and family history of AE or atopy. In addition, RAST and prick 
tests for 15 common allergens including birch and grass pollen 
were negative and total IgE was  ! 20 IU/ml. (3) Healthy volunteers 
(n = 4) without history and without clinical signs of atopy or oth-
er allergic diseases. (4) Patients with AE (n = 4) and sensitizations 
to grass and birch pollen but a negative APT. Biopsies from long-
lasting eczematous skin lesions (1 month) of an AE patient served 
as reference for a chronic lesion. None of the patients had received 
systemic steroids, antihistamines or UV light to the test site for at 
least 14 days prior to testing. The ethical committee of the Tech-
nical University of Munich approved the study.
 Pollen Patch Test and NPT
 Pollen patch tests (PPT) were performed using the standard-
ized procedure of APT  [18] with 1 mg intact pollen grains instead 
of pollen extracts. Commercially available grass ( Phleum pratense 
L.) and/or birch ( Betula alba L.) pollen (Allergon, Ängelholm, 
Sweden) were applied in large Finn chambers (11 mm in diameter) 
on the back of the patients using petrolatum as a carrier. Petrola-
tum alone served as a negative control. After 48 h the Finn cham-
bers were removed and the tested areas were marked. The test 
was evaluated after 48 and 72 h. Positive reactions were classified 
according to the European Task Force on Atopic Dermatitis 
(ETFAD) 2000 reading key  [8] . Epicutaneous provocation with 
nickel was performed using petrolatum containing 5% NiSO 4  
[nickel(II)-sulfate 5%, Hermal, Reinbeck, Germany] applied on 
the patients’ back for 48 h. The reactions were classified using the 
criteria of the International Contact Dermatitis Research Group 
and ranged between 1 and 3, according to the state of inflamma-
tion. 
 Tissue Processing and Staining
 Punch biopsy specimens (5 mm in diameter) were taken under 
local anesthesia (1% lidocaine) from the centre of the patch test 
areas at various time points (6, 24, 48, 72, 96 h after nickel/pollen 
application). Each patch test field was biopsied only once. Biopsies 
were immediately frozen at –70  °  C and stored until further han-
dling.
 From these biopsies, 4-  m-thick sagittal cryostat sections 
were performed on a freezing microtome (cryostat Leitz 1720, 
Wetzlar, Germany) and mounted on glass slides coated with poly-
 L -Lysine (Sigma, Munich, Germany). The slides were air-dried for 
2 h and then fixed for 10 min in dry acetone (Sigma). Two slides 
of all specimens were stained with haematoxylin-eosin. The im-
munohistochemical staining was performed in part in the ‘Tech 
Mate Horizon’ (Dako, Hamburg, Germany) ( table 1 ) according to 
the APAAP method.
 Some stainings were performed manually ( table 1 ): the sections 
were fixed with 3% buffered paraformaldehyde (Sigma) for 20 min, 
washed in Trizma base buffer (Sigma) containing 1% bovine serum 
albumin (Sigma) for 10 min and then incubated with the primary 
antibody diluted in antibody diluent (Dako, Hamburg, Germany) 
for 1 h. After washing for 10 min, the secondary antibody was add-
ed for 25 min. After this step and repeated washing, alkaline phos-
phatase was added for 25 min. The reactivity of this enzyme was 
visualized using the super sensitive detection kit (Bio Genex, San 
Ramon, Calif., USA). The activity of the alkaline phosphatase was 
inhibited by levamisole (Dako, Hamburg, Germany). Finally, all 
sections were washed again, slightly counterstained with haema-
laun, washed and mounted in gelatine (Merck, Haar, Germany). 
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 Light Microscopy: Quantification and Statistical Analysis
 Microscopic investigation was performed with the Axioplan2 
(Zeiss, Jena, Germany) light microscope. Immunohistochemical 
results were evaluated using the software programme ‘KS300’ de-
veloped by Zeiss which calculates the relative positive area in per-
cent and the absolute positive area in square micrometres by mea-
suring colour intensity. Quantification of two slides per stain was 
performed at 500 ! magnification in a blinded manner by two 
independent analyzers. Data from both analyzers was pooled. 
Quantification of the colour intensity was performed for dermis 
and epidermis. Since BDCA2 positivity was too low for a reliable 
online quantification, all BDCA2+ cells in a defined area (dermis 
and epidermis separately) were counted at 500 ! magnification 
by two independent investigators. The area of interest was defined 
using the software KS300. With these data, the number of cells 
per square millimetres was calculated for each biopsy.
 Student’s unpaired t test was used to compare the reactions of 
APT versus NPT and control groups. A p value  ! 0.05 was consid-
ered significant.
 Results
 Clinical Aspects of Patch Test Reactivity 
 Native pollen grains induced acute eczematous reac-
tions in patients with AE and known positive APT to pol-
len protein extracts 24–48 h after allergen application 
(data not shown). The test site showed an oedematous 
erythema with papules and seropapules resembling those 
seen in positive NPT. However, patients reacting to nick-
el showed a slower kinetics: eczematous reactions were 
seen after 48–72 h, while after 24 h none or only a slight 
erythema was observed. Notably, no acute eczematous 
reactions to native pollen grains were observed in AE pa-
tients with known sensitization against  P. pratense or  B. 
alba but negative APT in the past. None of our healthy 
controls showed a cutaneous reaction to native pollen 
grains. The petrolatum controls in all groups did not 
show any clinical signs of inflammation.
 Histological Evaluation of Skin Biopsy Specimens
 Hematoxylin-eosin-stained sections of biopsies taken 
from positive PPT and positive NPT showed a strong in-
flux of mononuclear cells into dermis and epidermis. Ac-
antholysis and intercellular oedema (spongiosis) were 
also observed in the epidermis. The strongest dermal and 
epidermal reaction was observed after 48 and 72 h for the 
PPT while the NPT showed a maximum after 72 and
96 h. After 96 h, the level of cellular infiltrate in the PPT 
was declining almost to the basic value, while in the NPT 
a strong infiltrate could still be observed ( fig. 1 a).
 Immunhistochemical Characterization of the T Cell 
Infiltrate
 Immunohistochemical analysis of the T cell infiltrate 
revealed that the majority of immigrating cells were 
CD3+CD4+ T cells both in NPT and PPT ( fig. 1 b,  2 ). 
 Table 1. Characterization of antibodies used for immunostaining
 Antibodies  Isotype  Clone  Dilution  Source 
 CD1a 1  IgG2a  NA1/34  1:50  Dako, Hamburg, Germany 
 CD3 1  polyclonal  polyclonal  prediluted  Dako, Hamburg, Germany 
 CD4 1  IgG1  EDU-2  1:50  NovoCastra, Dossenheim, Germany 
 CD8 1  IgG1  C8/144B  prediluted  Dako, Hamburg, Germany 
 CD25 1  IgG1  ACT-1  1:100  Dako, Hamburg, Germany 
 CD45RO 1  IgG2a  UCHL-1  prediluted  Dako, Hamburg, Germany 
 BDCA22  IgG1  AC144  AC144  Miltenyi Biotec, Bergisch Gladbach, Germany 
 CD1b 2  IgG1  IOT6b  1:100  Immunotech, Marseille, France 
 Fc  RI 2  29C6  IgG1  1:500  J. Hakimi and R. Chizzonite, 
 Hoffmann-La Roche, Nutley, N.J., USA 
 CD64 1  IgG1  10.1  1:100  BD Pharmingen, Heidelberg, Germany 
 CD68 1  IgG2b  Y1/82A  1:200  BD Pharmingen, Heidelberg, Germany 
 IFN-  2  IgG1  45.15  1:50  Alexis, Grünberg, Germany  
 IL-5 2  IgG1  9906.1  1:300  R&D, Minneapolis, Minn., USA  
 IgE 2  IgG1  CIA-E-7.12  1:300  Dako, Hamburg, Germany 
 1  Antibody was stained with the automated immunostainer, TechMate Horizon. 
 2  Antibody was stained manually. 
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 Fig. 1. Representative light micrographs of immunohistochemical 
stainings of PPT and NPT lesions.  a The kinetics (24–96 h after 
allergen application) of the influx of CD3+ cells in PPT and NPT 
is shown for one patient each.  b Characterization of the T cell in-
filtrate in PPT and NPT lesions (same patient as shown in  a ) at the 
climax of the immune reaction (PPT 48 h, NPT 96 h after allergen 
application).  c Immunohistochemical analysis of DC markers and 
IgE in NPT and PPT lesions, magnification for BDCA2 staining 
800 ! , scale = 20   m.  d Representative staining for the cytokines 
IFN-  and IL-5 and monocyte/macrophage markers in PPT and 
NPT lesions at 48 and 96 h after allergen application. HE = Hae-
matoxylin-eosin; Epid. = epidermis.  a–d Magnification 400 ! 
(scale = 50   m) unless otherwise stated.
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However, in APT the maximum influx of CD3+ T cells 
was lower compared to the NPT. An increase up to the 
late time point of 96 h of CD8+ cells was observed only 
in the NPT ( fig. 2 ), while CD8+ cells in the PPT increased 
from 6 to 24 h and then remained on a level lower than 
that of the NPT until 96 h after allergen application. 
CD4+ T cells increased continuously until 72 h in the 
PPT. In the case of NPT, a slight elevation until 48 h and 
a strong peak after 72 h were observed. Both reactions 
declined after 96 h. Both NPT and PPT showed primar-
ily an influx of CD45RO+ memory T cells. CD25+ cells 
showed a crescendo-decrescendo reaction both in NPT 
and PPT with a tendency – without significance (p = 0.2 
for 48 h, p = 0.1 for 72 h) – of a higher percentage in the 
PPT reaction ( fig.   1 b,  2 ).
 Analysis of Antigen-Presenting Markers and IgE
 IgE positivity strongly increased in the positive PPT 
biopsies up to 24 h after pollen application and decreased 
continuously until 96 h but displayed still elevated levels 
compared to the other groups ( fig.   1 c,  3 ). IgE was found 
neither in the NPT+ biopsies nor in sections of healthy 
controls ( fig. 3 ). Fc  RI-bearing cells were present after
24 h only in the PPT sections. They peaked at 24 h and 
remained elevated up to 96 h. Both, the chronic AE lesion 
and the non-lesional skin of AE patients showed slightly 
elevated levels of Fc  RI-bearing cells. Normal, healthy 
skin from the non-atopic patients was almost negative for 
Fc  RI. The number of CD1a+ cells appeared higher in the 
PPT than in the NPT biopsies which was significant after 
72 h (p = 0.037) ( fig. 3 ). The chronic AE lesion showed a 
higher expression of CD1a in the epidermis ( fig. 3 ). The 
most obvious difference between PPT and NPT occurred 
within the marker CD1b, staining primarily inflamma-
tory dendritic epidermal cells (IDEC)  [26] , although 
overall positivity was low compared to CD1a. CD1b+ 
cells increased in PPT rapidly between 6 and 24 h, peaked 
at 24 h and remained at elevated levels ( fig. 1 b,  3 ). In con-
trast, in the NPT an increase in CD1b+ cells was only 
observed after 72 h. In order to investigate the occurrence 
of plasmacytoid dendritic cells (pDC), we stained the sec-
tions for BDCA2. However, the rate of pDCs in all sec-
tions was too low for automatic quantification. So they 
were counted manually in the dermis and in the epider-
mis ( fig. 1 c,  3 ). Even though pDCs were present in the 
epidermis of both PPT and NPT lesions the occurrence 
of pDC was much lower compared to the dermis (ratio 
approximately 1:  5, depending on the different time 
points). Comparable to the IDECs, dermal pDCs peaked 
at 48 h in PPT biopsies. In NPT sections the highest num-
ber was observed after 72 h. CD64, Fc  receptor I, ex-
pressed on macrophages and monocytes showed, as CD1b 
and BDCA2, a much faster kinetics in PPT compared to 
NPT (significant difference after 24 h, p = 0.039) while 
the rate of CD68+ cells appeared equally over the time 
course in PPT and NPT, being slightly higher at 24 h
(p = 0.013) and 48 h (p = 0.528) in PPT sections but peak-
ing at 72 h in both reactions ( fig. 1 d,  3 ). Notably, a faint 
positivity for the markers CD1b, CD64, CD68 and Fc  RI 
was observed in the negative APT, both from patients 
with AE and healthy controls. 
 Cytokine Profile
 Sections were also stained for interleukin-5 (IL-5) and 
interferon-  (IFN-  ) in order to identify Th1- or Th2-
dominated immune responses. Both cytokine antibod -
 ies – IL-5 and IFN-  – showed typical cytoplasmic stain-
ing ( fig. 1 d). With regard to the T helper cell response, a 
clear dichotomy of the eczematous response to pollen in 
skin was observed while the NPT reaction was Th1 dom-
inated over the entire time course of the eczematous reac-
tion ( fig. 4 a, b). In the initiation phase of the eczematous 
reaction to pollen grains the IL-5 production was pre-
dominant over IFN-  production. In the late and chron-
ic phases the situation was reversed and IFN-  produc-
tion predominated over IL-5 production ( fig. 4 b). The bi-
phasic course of the cytokine profile in PPT became most 
evident by the ratio of IFN-  and IL-5 positivity in the 
cryosections ( fig. 4 a).
 Discussion
 Eczematous reactions caused by type I allergy-induc-
ing antigens seem to play a role in maintaining and exac-
erbating AE, and yet the underlying mechanisms of this 
immune reaction are not well understood. In this study, 
we characterized the in vivo  immune response to pollen 
grains immunohistochemically over a time course from 
6 to 96 h after allergen application and compared it to the 
well-defined delayed-type hypersensitivity reaction to 
nickel. We found that both reactions were comparable in 
principle, but differed in three points: the PPT reaction 
to pollen followed a faster kinetics, the maximum inten-
sity of the reaction was smaller and the infiltrating T cells 
showed a biphasic cytokine profile. 
 Concerning the T cell infiltrate, the maximum inten-
sity of the reaction reflected by the amount of CD3+ T 
cells was higher in NPT than PPT sections, but the PPT 
reaction followed a faster kinetics. CD8+ T cells became 
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 Fig. 2. Quantification of the T cell infiltrate in (PPT and NPT le-
sions: biopsies from PPT and NPT were taken 6–96 h after aller-
gen application and stained for CD3, CD45RO, CD8, CD4 and 
CD25. Stained cryosections were quantified with the aid of the 
computer program KS300 (Zeiss, Jena, Germany). Mean  8 SEM 
of the percentage of the relative positive area of the respective an-
tibody is shown from stained cryosections from 6 (positive PPT), 
5 (positive NPT), and 4 (negative PPT in healthy donors and neg-
ative PPT in AE– patients) different donors.  V = Significant (p  6 
0.05) differences between positive APT and NPT biopsies. Fur-
thermore, the results of the chronic AE lesion (CL, n = 2), the non-
lesional skin of atopic patients (NS AE+, n = 2) and normal skin 
of healthy volunteers (NS AE–, n = 2) are shown on the right of 
the diagrams.    
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more prominent in the NPT lesions especially at late time 
points (72 and 96 h) while they remained scarce in PPT 
sections. These results explain why a recent study inves-
tigating NPT described a much higher percentage of 
CD8+ when looking after 72 h  [27] . At an earlier time 
point, our in situ results approximately correlate to the in 
vitro results from Werfel et al.  [28]  showing a proportion 
of 10–15% CD8+ allergen-specific T cells from lesional 
AE skin. Our results confirm previous reports  [29, 30] 
demonstrating that more inflammatory cells are present 
in non-lesional AE skin compared to non-atopic skin, al-
beit in far smaller amounts than in lesional AE skin.
 In both acute eczematous reactions (PPT and NPT) a 
predominance of memory T cells (CD45RO+) was obvi-
ous. Furthermore, we detected a slightly enhanced ex-
pression of CD25 in the PPT compared to the NPT, but 
since CD25 is also expressed on DC, this could in part be 
due to the higher expression of DC markers in PPT and 
AE (chronic lesion and healthy skin of AE patient) and 
the earlier influx of DCs in PPT lesions.
 Cytokines produced by subsets of T cells may play a 
role in regulating some of the features of atopic allergic 
inflammation. Staining for IFN-  and IL-5 revealed that 
at the early time points (24 h) IL-5 dominated over the 
expression of IFN-  in the eczematous reaction to pollen 
grains while at the later time points (96 h) and in the 
chronic lesion IL-5 declined and an IFN-  dominance 
was observed. Thus, our observations of a biphasic course 
of the cytokine profile in acute eczematous reactions to 
native pollen grains extend previous studies performed 
on APT reactions to house dust mite  [31, 32] . Taking our 
recent findings into account, the early Th2 response in 
the skin and the high IgE positivity in the PPT sections 
could in part be due to Th2-polarizing substances such 
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 Fig. 3. Analysis of the expression of antigen-presenting cell mark-
ers and IgE in PPT and NPT lesions: cyrosections of all donors 
(see legend of fig.  2 ) were analyzed for the staining for IgE, Fc  RI, 
CD1a, CD1b (IDEC), BDCA2 (pDC in epidermis and dermis sep-
arately) and the macrophage and monocyte markers CD68 and 
CD64, respectively. Results are shown as mean values  8 SEM of 
positive staining area for the respective antibody quantified by 
KS300 computer software.  V = Significant (p  6 0.05) differences 
between positive PPT and NPT biopsies.
 Fig. 4. Analysis of the cytokine profile in PPT and NPT lesions.
 a Ratio of the quantified relative positive area of IFN-  and
IL-5 after 24–96 h after allergen application in NPT and PPT bi-
opsy cryosections.  b Mean  8 SEM of the quantified relative pos-
itive area for IFN-  and IL-5 in the time course of positive NPT 
(n = 5), APT (n = 6) and negative PPT (each n = 4) in AE patients 
and healthy controls. Furthermore, results from chronic AE le-
sion (CL, n = 2), non-lesional skin of atopic patients (NS AE+, n = 
2) and normal skin of healthy volunteers (NS AE–, n = 2) are 
shown on the right .  V = Significant (p  6 0.05) differences be-
tween positive PPT and NPT biopsies.  4 
 Eyerich et al.
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as phytoprostanes released from pollen itself  [23] . The re-
sults of NPT showing a Th1 pattern over the whole time 
course are in line with data from the literature  [33] . 
 At the same time as the change in cytokine profile in 
PPT, we observed a substantial influx of macrophages 
and monocytes (CD64+, CD68+ cells) at PPT sites. Re-
cently, macrophage-produced IL-12 was shown to be able 
to induce Th1 development in vitro  [34] . This suggests 
that the influx of macrophages might induce a change in 
local skin microenvironment favouring IFN-  . Interest-
ingly, in the PPT lesion the decrease in early peaking IgE 
is accompanied by the increase in CD64, CD68 and the 
switch to the Th1 domination. 
 The elicitation of contact dermatitis presumably re-
quires close interactions between infiltrating T cells and 
antigen-presenting cells, which either reside in the skin 
or migrate from blood. Langerhans cells are the resident 
DC population in skin epidermis where they form a con-
tiguous network to detect any invading pathogen or an-
tigen  [35] . The significantly higher number of CD1a-ex-
pressing cells in the skin of AE patients as shown in the 
present study is of special interest with regard to the re-
cent publication showing that lipids from pollen are pre-
sented in a CD1-restricted manner  [36, 37] . A second 
CD1a+ epidermal DC population, the so-called IDEC 
 [38] , has been described to be the relevant IgE-binding, 
Fc  RI-expressing epidermal DC population in AE  [39, 
40] . In our study, CD1b, staining primarily IDECs, oc-
curred in PPT as early as 24 h after pollen application 
while in the NPT an increase in CD1b positivity was ob-
served earliest after 72 h. This marker thus correlates 
with the faster clinical manifestation of acute eczema in 
PPT. Furthermore, it underlines the central role of IDECs 
in the development of the eczematous reactions in the 
early phase  [26] . In the chronic AE lesion CD1b+ cells 
were scarce, but still more highly expressed than in non-
lesional and healthy skin. In contrast to that, CD1a was 
also highly expressed in chronic lesions suggesting that 
the DC alteration during skin lesion formation can be 
subdivided into early and late events, with the influx of 
IDECs as an early event and the predominance of CD1a+ 
cells as a late event. 
 pDC, also known as natural IFN-  /  -producing cells 
 [41] , have been described to be present in skin in contact 
dermatitis and psoriasis and in a lower number in AE 
 [42] , where their inactivity is associated with eczema her-
peticatum  [43] . We observed an earlier influx of pDCs 
into the dermis in PPT (24 h) compared to the NPT
(48 h). However, the percentage of pDCs in the epidermis 
was very low both in PPT and NPT lesions. 
 Negative results of PPT in patients with AE and sensi-
tizations to pollen allergens were also observed by other 
authors  [44] . It opens the question whether skin or even 
keratinocyte-specific factors play a role in these mecha-
nisms. This idea is strengthened by the observation of 
positive PPT reactions in patients without sensitizations, 
intrinsic or non-AE, which were associated with an in-
flux of IDEC  [15] . Furthermore, this observation argues 
for allergen-specific rather than irritative factors ac-
counting for eczematous reactions to native pollen grains. 
A question which cannot be answered in our setting of 
experiments, to some extent because of the low numbers 
of patients, is whether pollen grains are more competent 
to induce eczematous reactions compared to the prepared 
protein extracts for the APT.
 In summary, we conclude that pollen grains induce an 
inflammatory reaction in susceptible individuals with 
AE. This reaction appears clinically and immunohisto-
chemically similar to the known contact hypersensitivity 
reaction to nickel but follows a faster kinetics and a bi-
phasic course – IL-5 and IgE in the early and IFN-  pre-
dominance in the late phase. The faster kinetics was also 
reflected by the rapid occurrence of DC, especially IDEC. 
Whether the early IL-5 dominance could be in part due 
to the recently described Th2-polarizing pollen-associ-
ated lipid mediators remains to be investigated.
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